0
Rhinomed Limited Banner Image

Rhinomed Limited

  • Ticker RNO
    Exchange ASX More
  • Industry --None-- More
  • Sector Healthcare More
Rhinomed Limited Logo Image
  • 11-50 Employees
  • Based in Cremorne, Australia
Rhinomed Limited engages in the research, development, and commercialization of consumer and medical devices worldwide. It identifies, acquires, and commercializes nasal stent delivery technologies. The company's product portfolio includes Turbine for enhanced breathing in sports; Mute, an anti-snoring device; Pronto, a vapor inhaler to improve airflow and better sleep; and Rhinoswab thatMore is used to collect a nasal swab. It also engages in developing programs in various markets, including sleep and sleep architecture, the impact of sleep and respiratory, function on cognitive issues, obstructive sleep apnea, pain, nausea, respiratory disease, and diagnostics and sensors; and offers a drug delivery platform for the delivery of cannabinoid formulations. The company was formerly known as Consegna Group Limited and changed its name to Rhinomed Limited in November 2013. Rhinomed Limited was incorporated in 2004 and is based in Cremorne, Australia.
Rhinomed Limited

Most Recent Annual Report

Rhinomed Limited
MOST RECENT 2021 Annual Report

Older/Archived Annual Reports